
Employer health-plan costs projected to rise 8.2% in 2027, driven by drugs and billing disputes
A Marsh survey of more than 1,800 employers shows employer-sponsored health-insurance costs are projected to climb 8.2% in 2027, the largest rise in over two decades. Drivers include the uptake of GLP-1 weight-loss drugs, AI-based billing by medical providers, and a 2022 federal dispute-resolution process that has produced numerous medical-billing disputes and higher payouts, with hospital consolidation and advanced cancer care also pushing costs. Workers could face higher premiums or reduced coverage, and even with cost-control measures, costs would still rise—about 11% without changes to plans.

